VDAC2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.487640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.165800E-01
Normal-vs-Stage2
1.582610E-01
Normal-vs-Stage3
3.373800E-01
Normal-vs-Stage4
1.038580E-01
Stage1-vs-Stage2
6.556000E-01
Stage1-vs-Stage3
8.206800E-01
Stage1-vs-Stage4
7.366200E-01
Stage2-vs-Stage3
9.649200E-01
Stage2-vs-Stage4
9.866400E-01
Stage3-vs-Stage4
9.665000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.614020E-01
Normal-vs-AfricanAmerican
7.496100E-02
Normal-vs-Asian
7.869700E-02
Caucasian-vs-AfricanAmerican
6.901200E-01
Caucasian-vs-Asian
9.163200E-01
AfricanAmerican-vs-Asian
6.785800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.656400E-02
Normal-vs-Female
2.672400E-01
Male-vs-Female
3.552400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.484800E-01
Normal-vs-Age(41-60Yrs)
3.005700E-02
Normal-vs-Age(61-80Yrs)
2.326400E-01
Normal-vs-Age(81-100Yrs)
7.327700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.766650E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.907000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.139600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.745600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.837800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.760000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.636420E-01
Normal-vs-Daily Drinker
1.520360E-01
Normal-vs-Weekly Drinker
5.704200E-02
Normal-vs-Occasional Drinker
1.529940E-02
Normal-vs-Social Drinker
1.380760E-01
Non Drinker-vs-Daily Drinker
9.036400E-01
Non Drinker-vs-Weekly Drinker
4.759400E-01
Non Drinker-vs-Occasional Drinker
1.978170E-01
Non Drinker-vs-Social Drinker
7.186600E-01
Daily Drinker-vs-Weekly Drinker
5.143600E-01
Daily Drinker-vs-Occasional Drinker
2.623400E-01
Daily Drinker-vs-Social Drinker
6.469800E-01
Weekly Drinker-vs-Occasional Drinker
8.776200E-01
Weekly Drinker-vs-Social Drinker
3.842200E-01
Occasional Drinker-vs-Social Drinker
9.196400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.779980E-01
Normal-vs-Grade 2
1.650630E-01
Normal-vs-Grade 3
6.692000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.063800E-03
Grade 1-vs-Grade 3
1.040090E-02
Grade 1-vs-Grade 4
1.779980E-01
Grade 2-vs-Grade 3
9.453600E-01
Grade 2-vs-Grade 4
1.650630E-01
Grade 3-vs-Grade 4
6.692000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.350160E-01
Normal-vs-NonDiabetic
1.635220E-01
Diabetic-vs-NonDiabetic
9.147400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.296000E-02
Normal-vs-NoPancreatitis
1.763990E-01
Pancreatitis-vs-NoPancreatitis
2.254200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.318100E-02
Normal-vs-N1
1.868040E-01
N0-vs-N1
4.681400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.033590E-01
Normal-vs-TP53-NonMutant
3.313000E-01
TP53-Mutant-vs-TP53-NonMutant
1.404030E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
